Healthcare provider profile · identity verified

Steven E. Johnson, M.D.

Internal Medicine · FORT WORTH, TX · NPI 1801837935

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	933	301
Losartan Potassium	Losartan Potassium	718	213
Levothyroxine Sodium	Levothyroxine Sodium	522	129
Amlodipine Besylate	Amlodipine Besylate	514	145
Escitalopram Oxalate	Escitalopram Oxalate	395	103
Metoprolol Succinate	Metoprolol Succinate	363	106
Lisinopril	Lisinopril	356	112
Rosuvastatin Calcium	Rosuvastatin Calcium	343	114
Trazodone Hcl	Trazodone Hcl	286	85
Simvastatin	Simvastatin	254	76
Metformin Hcl	Metformin Hcl	253	74
Hydrochlorothiazide	Hydrochlorothiazide	215	69
Glimepiride	Glimepiride	206	61
Metformin Hcl Er	Metformin Hcl	203	65
Gabapentin	Gabapentin	198	65
Pantoprazole Sodium	Pantoprazole Sodium	192	60
Omeprazole	Omeprazole	185	58
Pravastatin Sodium	Pravastatin Sodium	161	52
Jardiance	Empagliflozin	149	33
Eliquis	Apixaban	138	34
Montelukast Sodium	Montelukast Sodium	124	39
Allopurinol	Allopurinol	111	34
Furosemide	Furosemide	110	42
Tamsulosin Hcl	Tamsulosin Hcl	109	35
Buspirone Hcl	Buspirone Hcl	108	34
Ezetimibe	Ezetimibe	108	36
Synthroid	Levothyroxine Sodium	106	25
Ozempic	Semaglutide	101	22
Bupropion Xl	Bupropion Hcl	96	32
Atenolol	Atenolol	93	24
Alprazolam	Alprazolam	89	33
Donepezil Hcl	Donepezil Hcl	86	25
Sertraline Hcl	Sertraline Hcl	85	24
Fluticasone Propionate	Fluticasone Propionate	70	23
Doxazosin Mesylate	Doxazosin Mesylate	65	17
Duloxetine Hcl	Duloxetine Hcl	64	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	21
Citalopram Hbr	Citalopram Hydrobromide	63	17
Metoprolol Tartrate	Metoprolol Tartrate	63	24
Spironolactone	Spironolactone	63	20
Albuterol Sulfate Hfa	Albuterol Sulfate	62	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	18
Potassium Chloride	Potassium Chloride	59	22
Meloxicam	Meloxicam	58	19
Tramadol Hcl	Tramadol Hcl	56	14
Carvedilol	Carvedilol	54	17
Celecoxib	Celecoxib	54	13
Clopidogrel	Clopidogrel Bisulfate	52	18
Tizanidine Hcl	Tizanidine Hcl	51	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	50	12
Zolpidem Tartrate	Zolpidem Tartrate	50	19
Azithromycin	Azithromycin	48	45
Alendronate Sodium	Alendronate Sodium	46	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	38
Farxiga	Dapagliflozin Propanediol	44	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	44	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	17
Clonazepam	Clonazepam	42	12
Famotidine	Famotidine	39	17
Finasteride	Finasteride	39	11
Olmesartan Medoxomil	Olmesartan Medoxomil	37	11
Myrbetriq	Mirabegron	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Terazosin Hcl	Terazosin Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	32	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	suppressed
Estradiol	Estradiol	30	suppressed
Methylprednisolone	Methylprednisolone	30	29
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	26
Paxlovid	Nirmatrelvir/Ritonavir	30	30
Verapamil Er	Verapamil Hcl	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	25
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Rybelsus	Semaglutide	28	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Tresiba Flextouch U-200	Insulin Degludec	27	suppressed
Risedronate Sodium	Risedronate Sodium	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	23
Glyxambi	Empagliflozin/Linagliptin	22	suppressed
Humulin R	Insulin Regular, Human	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Ramipril	Ramipril	22	suppressed
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Lovastatin	Lovastatin	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Valsartan	Valsartan	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Bydureon Bcise	Exenatide Microspheres	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Prednisone	Prednisone	19	13
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Primidone	Primidone	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Glipizide	Glipizide	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	13	suppressed
Cefdinir	Cefdinir	13	12
Colchicine	Colchicine	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Linzess	Linaclotide	13	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Risperidone	Risperidone	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Eletriptan Hbr	Eletriptan Hydrobromide	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error